Academic Journal
View in EDS

A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib

Bibliographic Details
Title: A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
Authors: Moran, Teresa, Palmero, Ramón, Provencio, Mariano, Insa, Amelia, Majem, Margarita, Reguart, Noemí, Bosch-Barrera, Joaquim, Isla, Dolores, Costa, Enric Carcereny, Lee, Chooi, Puig, Marta, Kraemer, Sandrine, Schnell, David, Rosell, Rafael
Source: In Lung Cancer June 2017 108:154-160
Database: ScienceDirect
More Details
ISSN:01695002
DOI:10.1016/j.lungcan.2017.03.009
Published in:Lung Cancer
Language:English